Abstract:VSMCs (vascular smooth muscle cells) play critical roles in arterial remodelling with aging, hypertension and atherosclerosis. VSMCs exist in diverse phenotypes and exhibit phenotypic plasticity, e.g. changing from a quiescent/contractile phenotype to an active myofibroblast-like, often called 'synthetic', phenotype. Synthetic VSMCs are able to proliferate, migrate and secrete ECM (extracellular matrix) proteinases and ECM proteins. In addition, they produce pro-inflammatory molecules, providing an inflammatory microenvironment for leucocyte penetration, accumulation and activation. The aging VSMCs have also shown changes in cellular phenotype, responsiveness to contracting and relaxing mediators, replicating potential, matrix synthesis, inflammatory mediators and intracellular signalling. VSMC dysfunction plays a key role in age-associated vascular remodelling. Cyclic nucleotide PDEs (phosphodiesterases), by catalysing cyclic nucleotide hydrolysis, play a critical role in regulating the amplitude, duration and compartmentalization of cyclic nucleotide signalling. Abnormal alterations of PDEs and subsequent changes in cyclic nucleotide homoeostasis have been implicated in a number of different diseases. In the study published in the latest issue of Clinical Science, Bautista Niño and colleagues have shown that, in cultured senescent human VSMCs, PDE1A and PDE1C mRNA levels are significantly up-regulated and inhibition of PDE1 activity with vinpocetine reduced cellular senescent makers in senescent VSMCs. Moreover, in the premature aging mice with genomic instability (Ercc1(d/-)), impaired aortic ring relaxation in response to SNP (sodium nitroprusside), an NO (nitric oxide) donor, was also largely improved by vinpocetine. More interestingly, using data from human GWAS (genome-wide association studies), it has been found that PDE1A single nucleotide polymorphisms is significantly associated with diastolic blood pressure and carotid intima-media thickening, two hallmarks of human vascular dysfunction in aging. These findings establish a strong relationship between PDE1 expression regulation and vascular abnormalities in aging.

Molecular explanation of Wnt/βcatenin antagonist pyrvinium mediated calcium equilibrium changes in aging cardiovascular disorders

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging.

Mechanical microenvironment regulation of age-related diseases involving degeneration of human skeletal and cardiovascular systems.

Impact of Aging on Cardiovascular Diseases

Molecular Mechanisms of Vascular Health: Insights From Vascular Aging and Calcification

Cardiovascular aging: from cellular and molecular changes to therapeutic interventions

The role of cardiomyocyte senescence in cardiovascular diseases: A molecular biology update

Calcium cycling in the aged heart

Molecular insights into mitoepigenetic stress response signaling in age-associated cardiovascular disease risk

Wnt 3a Protects Myocardial Injury in Elderly Acute Myocardial Infarction by Inhibiting Serum Cystatin C/ROS-Induced Mitochondrial Damage

The Senescent Heart—"Age Doth Wither Its Infinite Variety"

Cathepsin K knockout alleviates aging-induced cardiac dysfunction.

Aging-Induced Biological Changes and Cardiovascular Diseases

Targeting Molecular Mechanism of Vascular Smooth Muscle Senescence Induced by Angiotensin II, A Potential Therapy via Senolytics and Senomorphics

Attenuation of Aging-Induced Vascular Dysfunction by Inhibition of Ca2+/Calmodulin Protein Kinase II (CaMKII) in Isolated Renal and Carotid Rat Arteries

Cardiac Molecular Analysis Reveals Aging-Associated Metabolic Alterations Promoting Glycosaminoglycans Accumulation via Hexosamine Biosynthetic Pathway

The Implications of Aging on Vascular Health

Functional, Structural and Proteomic Effects of Ageing in Resistance Arteries

Cyclic nucleotide phosphodiesterase 1 and vascular aging

The Role of Oxidative Stress and Inflammation in Cardiovascular Aging